Phathom Pharmaceuticals

Price & Volume

Stats

52W Range	$5.21-$19.71
Market Cap	$387.6M
Shares Short	14M

Financials

Revenue (12 Mos)	$26.2M
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$21.9M
Diluted EPS	-$5.74

News

Yahoo Finance • 25 days ago

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

Yahoo Finance • last year

Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital

Yahoo Finance • last year

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Yahoo Finance • last year

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)

About

CEO	Ms. Terrie J. Curran
Address	100 Campus Drive, Florham Park, NJ, United States, 07932
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	452